Cathie Wood's Q2 Portfolio Reshuffle: Buying SpaceX, Eli Lilly, Meta While Trimming AMD
Taylor Wilson
ARK Invest completed a major portfolio reshuffle ahead of Q2, with SpaceX drawing the largest single buy at ~$52.1 million while AMD and Roku were trimmed — a deliberate pivot from semiconductors and streaming hardware toward space, biopharma, and social platforms.
Where did the money go?
The biggest ticket was SpaceX: ARK added ~349,000 shares across ARKK, ARKQ, ARKW, and ARKX, totaling ~$52.1 million.
Eli Lilly followed at ~$25.8 million; Meta also received fresh buying.
This means → ARK's new money flowed into three lanes: commercial space, biopharma, and social-media platforms — all deliberately away from chips and hardware.
What was sold, and what does that signal?
ARK trimmed both AMD and Roku, actively shrinking its semiconductor and streaming-hardware exposure.
In plain terms = at the quarter-turn, Cathie Wood swapped tracks — moving chips from chipmakers and hardware sellers into drugmakers, platforms, and rockets.
This reflects a cautious near-term read on the semiconductor cycle and a preference shift toward platform-scale and frontier-tech names.
SpaceX got the largest inflow — why does that matter?
SpaceX is a privately held company; retail investors cannot buy it directly on public markets. ARK accesses it through private-market share allocations.
This means → Wood is willing to place her single largest bet on the least liquid yet highest-growth-expectation asset in her portfolio — a strong confidence vote on SpaceX's valuation trajectory.
For everyday investors, the move signals that ARK sees rising certainty in the commercial-space theme, worth watching through ARK's publicly traded funds.
Content is for reference only, not financial advice.